JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hayashi, T.
Right arrow Articles by Yamawaki, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hayashi, T.
Right arrow Articles by Yamawaki, S.

Modulation by sigma ligands of intracellular free Ca++ mobilization by N-methyl-D-aspartate in primary culture of rat frontal cortical neurons

T Hayashi, A Kagaya, M Takebayashi, M Shimizu, Y Uchitomi, N Motohashi and S Yamawaki

Department of Psychiatry and Neurosciences, Hiroshima University School of Medicine, Japan.

Despite substantial data on radioligand binding to the sigma receptor, neither the physiologic function nor the intracellular mechanism of this receptor is known. In this study, we examined the effect of sigma ligands on Ca++ influx induced by N-methyl-D-aspartate (NMDA) in single primary cultured rat frontal cortical neurons with fluorescence video microscopy. All sigma ligands tested reduced the NMDA-induced increase in intracellular Ca++ concentration ([Ca++]i) in a dose-dependent manner with IC50 values in the low micromolar range. Inhibition by haloperidol and (+)-N-cyclopropylmethyl-N-methyl-1,4-diphenyl-1-ethyl- but-3-en-1-ylam ine hydrochloride (JO1784) was noncompetitive; but, exogenous glycine (100 microM) did not alter their IC50 values. In addition, haloperidol (1 microM) enhanced Mg+(+)-mediated inhibition of the NMDA-induced [Ca++]i increase (IC50 = 0.45 +/- 0.01 mM vs. an IC50 = 0.98 +/- 0.06 mM for Mg++ alone). Selective sigma receptor ligands (JO1784, (+)-pentazocine) caused a greater reduction of the sustained phase of the Ca++ response to NMDA, whereas haloperidol and DTG reduced both the initial and sustained phase of the response to a similar degree. The rank order of potencies for inhibition of both the sustained Ca++ response phase and (+)-[3H]SKF-10047 binding (Roman et al., J. Pharm. Pharmacol. 42: 439-440, 1989) were similar. These findings suggest that sigma 1 ligands indirectly modulate NMDA receptor complex function through sigma 1 receptors and that sigma ligands facilitate the desensitization of the Ca++ response to NMDA.

Volume 275, Issue 1, pp. 207-214, 10/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Herrera, C. Katnik, J. D. Rodriguez, A. A. Hall, A. Willing, K. R. Pennypacker, and J. Cuevas
{sigma}-1 Receptor Modulation of Acid-Sensing Ion Channel a (ASIC1a) and ASIC1a-Induced Ca2+ Influx in Rat Cortical Neurons
J. Pharmacol. Exp. Ther., November 1, 2008; 327(2): 491 - 502.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. T. Tchedre, R.-Q. Huang, A. Dibas, R. R. Krishnamoorthy, G. H. Dillon, and T. Yorio
Sigma-1 Receptor Regulation of Voltage-Gated Calcium Channels Involves a Direct Interaction
Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 4993 - 5002.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. T. Tchedre and T. Yorio
{sigma}-1 Receptors Protect RGC-5 Cells from Apoptosis by Regulating Intracellular Calcium, Bax Levels, and Caspase-3 Activation
Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2577 - 2588.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Katnik, W. R. Guerrero, K. R. Pennypacker, Y. Herrera, and J. Cuevas
Sigma-1 Receptor Activation Prevents Intracellular Calcium Dysregulation in Cortical Neurons during in Vitro Ischemia
J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1355 - 1365.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
L. Wang, A. R. Prescott, B. A. Spruce, J. Sanderson, and G. Duncan
Sigma Receptor Antagonists Inhibit Human Lens Cell Growth and Induce Pigmentation
Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1403 - 1408.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Hayashi and T.-P. Su
Sigma-1 receptors at galactosylceramide-enriched lipid microdomains regulate oligodendrocyte differentiation
PNAS, October 12, 2004; 101(41): 14949 - 14954.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
F. P. Monnet, M. P. Morin-Surun, J. Leger, and L. Combettes
Protein Kinase C-Dependent Potentiation of Intracellular Calcium Influx by {sigma}1 Receptor Agonists in Rat Hippocampal Neurons
J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 705 - 712.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Z. Mtchedlishvili and J. Kapur
A Presynaptic Action of the Neurosteroid Pregnenolone Sulfate on GABAergic Synaptic Transmission
Mol. Pharmacol., October 1, 2003; 64(4): 857 - 864.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
H. Zhang and J. Cuevas
Sigma Receptors Inhibit High-Voltage-Activated Calcium Channels in Rat Sympathetic and Parasympathetic Neurons
J Neurophysiol, June 1, 2002; 87(6): 2867 - 2879.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Hayashi and T.-P. Su
Regulating ankyrin dynamics: Roles of sigma-1 receptors
PNAS, January 5, 2001; (2001) 21413698.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
T. Hayashi, T. Maurice, and T.-P. Su
Ca2+ Signaling via sigma 1-Receptors: Novel Regulatory Mechanism Affecting Intracellular Ca2+ Concentration
J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 788 - 798.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
O. Soriani, F. L. Foll, F. Roman, F. P. Monnet, H. Vaudry, and L. Cazin
A-Current Down-Modulated by sigma  Receptor in Frog Pituitary Melanotrope Cells Through a G Protein-Dependent Pathway
J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 321 - 328.
[Abstract] [Full Text]


Home page
StrokeHome page
A. Bhardwaj, M. Sawada, E. D. London, R. C. Koehler, R. J. Traystman, J. R. Kirsch, and F. M. Faraci
Potent {varsigma}1-Receptor Ligand 4-Phenyl-1-(4-Phenylbutyl) Piperidine Modulates Basal and N-Methyl-D-Aspartate–Evoked Nitric Oxide Production In Vivo • Editorial Comment
Stroke, November 1, 1998; 29(11): 2404 - 2411.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
O. Soriani, H. Vaudry, Y. A. Mei, F. Roman, and L. Cazin
Sigma Ligands Stimulate the Electrical Activity of Frog Pituitary Melanotrope Cells through a G-Protein-Dependent Inhibition of Potassium Conductances
J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 163 - 171.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
E. R. Whittemore, V. I. Ilyin, and R. M. Woodward
Antagonism of N-Methyl-D-Aspartate Receptors by sigma  Site Ligands: Potency, Subtype-Selectivity and Mechanisms of Inhibition
J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 326 - 338.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Hayashi and T.-P. Su
Regulating ankyrin dynamics: Roles of sigma-1 receptors
PNAS, January 16, 2001; 98(2): 491 - 496.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1995 by the American Society for Pharmacology and Experimental Therapeutics.